Matter

KBP Biosciences Pte Ltd and another v Novo Nordisk A/S

Seat: United States

14 May 2026Singapore
14 May 2026Singapore
Judgment of the Court of Appeal of Singapore in the case [2026] SGCA(I) 2 dated 14 May 2026
Court of Appeal of Singapore
Decision summary
The court dismissed the appeal and upheld the refusal to set aside the worldwide freezing order, subject to a minor variation that was not appealed. It held that section 12A of Singapore's International Arbitration Act 1994 empowered the court to grant urgent interim relief in support of the New York-seated arbitration because the arbitral tribunal could not act effectively at the relevant time.
Supporting details
8 authorities · 8 participants
KBP Biosciences Pte Ltd
Representative
Mr Cavinder Bull SC (For: KBP Biosciences Pte Ltd · Dr Huang Zhenhua)
Dr Huang Zhenhua
Representative
Mr Cavinder Bull SC (For: KBP Biosciences Pte Ltd · Dr Huang Zhenhua)
Novo Nordisk A/S
Representative
Mr Ong Tun Wei Danny SC (For: Novo Nordisk A/S)
Court of Appeal of Singapore
Judge
Judith Prakash SJ
Judge
Lady Arden IJ
Judge
Philip Jeyaretnam J
Authorities cited
8
- Singapore International Arbitration Act 1994 (2020 Rev Ed) (International Arbitration Act 1994 (2020 Rev Ed))
  statute
- Singapore International Commercial Court Rules 2021
  procedural rules
- JTrust Asia Pte Ltd v Group Lease Holdings Pte Ltd ([2018] 2 SLR 159)
  case
- Yves Charles Edgar v Accent Delight International Ltd ([2015] 5 SLR 558)
  case
- Spectramed Pte Ltd v Lek Puay Puay ([2010] SGHC 112)
  case
- Tay Long Kee Impex Pte Ltd v Tan Beng Huwah ([2000] 1 SLR(R) 786)
  case
- Nomura Regionalisation Venture Fund Ltd v Ethical Investments Ltd ([2000] 2 SLR(R) 926)
  case
- Re Sprintroom Ltd ([2019] 2 BCLC 617)
  case
Direct judgment

KBP Biosciences Pte Ltd

Dr Huang Zhenhua

Novo Nordisk A/S

Court of Appeal of Singapore